Form 4: SeaStar Medical Holding Corp: Director Awarded RSUs

SeaStar Medical Holding Corp reports a restricted stock unit award to Director Bernadette N. Vincent, with vesting scheduled for July 1, 2027.

Summary

• Bernadette N. Vincent, a Director at SeaStar Medical Holding Corp, was awarded 4,000 restricted stock units (RSUs) on July 1, 2026.
• These RSUs are scheduled to vest in full on July 1, 2027.
• Following this award, Vincent's beneficial ownership of common stock is 8,200 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity award to a director rather than significant financial performance or strategic shifts.

Positives

• Director Bernadette N. Vincent received an award of 4,000 RSUs, indicating continued investment and alignment with the company's long-term prospects.
• The RSUs are set to vest, providing a future incentive for the director.

Future Outlook

The filing does not contain specific forward-looking financial statements or guidance. The vesting of RSUs on July 1, 2027, represents a future event tied to continued service.

Industry Context

StockSavvy.ai notes that the issuance of equity awards to directors is a common practice in the biotechnology and medical technology sectors, aligning executive and director interests with shareholder value over the long term.

Stakeholder Impact

• Shareholders: The award aligns director incentives with long-term shareholder value, though it represents a future dilution event upon vesting.
• Employees: Standard practice for director compensation, not directly impacting other employees.
• Management: Reinforces alignment of governance with company performance.

Next Steps

• The RSUs awarded to Bernadette N. Vincent will vest on July 1, 2027, contingent upon continued service.

Key Dates

Keywords

SeaStar Medical Holding Corp, ICU, Form 4, SEC Filing, Director, Restricted Stock Units, RSU Award, Beneficial Ownership, Stock Vesting